United States Biotechnology & Medical Research

Ra Pharmaceuticals Inc (RARX)

Track

Track

Ticker: RARX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Ricardo Alonso See Remarks Officer
Transaction date
Planned sale
Price
383.41
Quantity 97,827 +12.6%
Value US$1,569,499
Farzaneh-Far Ramin Chief Medical Officer Officer
Transaction date
Planned sale
Price
25.78
Quantity 52,063 -6.7%
Value US$3,868,016
Farzaneh-Far Ramin Chief Medical Officer Officer
Transaction date
Planned sale
Price
44.39
Quantity 31,311 -46.3%
Value US$1,735,572
Ricardo Alonso See Remarks
Transaction date
Planned sale
Price
47.02
Quantity 2,285 -50.0%
Value US$107,441
Farzaneh-Far Ramin Chief Medical Officer
Transaction date
Planned sale
Price
46.95
Quantity 10,595 -59.8%
Value US$497,441
Read Simon Chief Scientific Officer Officer
Transaction date
Planned sale
Price
47.08
Quantity 10,000 -61.6%
Value US$470,821
Ricardo Alonso See Remarks Officer
Transaction date
Planned sale
Price
47.08
Quantity 2,285 -33.3%
Value US$107,568
Farzaneh-Far Ramin Chief Medical Officer Officer
Transaction date
Planned sale
Price
47.23
Quantity 10,595 -59.8%
Value US$500,351
Farzaneh-Far Ramin Chief Medical Officer Officer
Transaction date
Planned sale
Price
46.66
Quantity 10,595 -59.8%
Value US$494,319
Read Simon Chief Scientific Officer Officer
Transaction date
Planned sale
Price
46.68
Quantity 10,000 -61.6%
Value US$466,808
Ricardo Alonso See Remarks
Transaction date
Planned sale
Price
46.70
Quantity 2,285 -25.0%
Value US$106,710
2.8
Read Simon Chief Scientific Officer
Transaction date
Planned sale
Price
46.87
Quantity 10,000 -61.6%
Value US$468,726
Farzaneh-Far Ramin Chief Medical Officer
Transaction date
Planned sale
Price
46.89
Quantity 10,595 -59.8%
Value US$496,769
Farzaneh-Far Ramin Chief Medical Officer
Transaction date
Planned sale
Price
25.26
Quantity 10,595 -59.8%
Value US$267,675
2.8
Read Simon Chief Scientific Officer
Transaction date
Planned sale
Price
25.41
Quantity 10,000 -61.6%
Value US$254,050
Ricardo Alonso See Remarks Officer
Transaction date
Planned sale
Price
27.89
Quantity 2,285 -20.0%
Value US$63,740
Read Simon Chief Scientific Officer Officer
Transaction date
Planned sale
Price
27.77
Quantity 10,000 -61.6%
Value US$277,703
Farzaneh-Far Ramin Chief Medical Officer Officer
Transaction date
Planned sale
Price
27.77
Quantity 10,595 -59.8%
Value US$294,226
2.8
Read Simon Chief Scientific Officer
Transaction date
Planned sale
Price
32.95
Quantity 10,000 -61.6%
Value US$329,479
Farzaneh-Far Ramin Chief Medical Officer
Transaction date
Planned sale
Price
33.29
Quantity 4,216 -37.2%
Value US$140,338
Farzaneh-Far Ramin Chief Medical Officer
Transaction date
Planned sale
Price
32.97
Quantity 6,379 -36.0%
Value US$210,309
Ricardo Alonso See Remarks
Transaction date
Planned sale
Price
23.72
Quantity 2,857 -20.0%
Value US$67,782
2.8
Read Simon Chief Scientific Officer
Transaction date
Planned sale
Price
23.09
Quantity 414 -6.2%
Value US$9,560
2.8
Read Simon Chief Scientific Officer
Transaction date
Planned sale
Price
22.21
Quantity 9,586 -59.0%
Value US$212,908
Farzaneh-Far Ramin Chief Medical Officer
Transaction date
Planned sale
Price
22.04
Quantity 7,184 -50.2%
Value US$158,363
Farzaneh-Far Ramin Chief Medical Officer
Transaction date
Planned sale
Price
21.41
Quantity 3,411 -19.2%
Value US$73,021
Shah Rajeev M. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
15.50
Quantity 1,006,452 +26.1%
Value US$15,600,006
NEW ENTERPRISE ASSOCIATES 13 LP Large shareholder
Transaction date
Purchase
Price
15.50
Quantity 645,161 +11.8%
Value US$9,999,996
RA CAPITAL MANAGEMENT, LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
15.50
Quantity 1,006,452 +26.1%
Value US$15,600,006
NEW ENTERPRISE ASSOCIATES 13 LP Large shareholder
Transaction date
Purchase
Price
6.00
Quantity 2,000,000 +57.3%
Value US$12,000,000
RA CAPITAL MANAGEMENT, LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
6.00
Quantity 2,500,000 +184.9%
Value US$15,000,000
Shah Rajeev M. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
6.00
Quantity 2,500,000 +184.9%
Value US$15,000,000
Novartis Bioventures Ltd Large shareholder
Transaction date
Sale
Price
22.02
Quantity 3,220 -0.1%
Value US$70,899
Novartis Bioventures Ltd Large shareholder
Transaction date
Sale
Price
21.24
Quantity 53,200 -2.3%
Value US$1,130,207
Novartis Bioventures Ltd Large shareholder
Transaction date
Sale
Price
22.00
Quantity 700 -0.0%
Value US$15,400
Novartis Bioventures Ltd Large shareholder
Transaction date
Sale
Price
22.11
Quantity 4,840 -0.2%
Value US$106,999
Novartis Bioventures Ltd Large shareholder
Transaction date
Sale
Price
22.98
Quantity 7,274 -0.3%
Value US$167,161
Novartis Bioventures Ltd Large shareholder
Transaction date
Sale
Price
23.11
Quantity 4,780 -0.2%
Value US$110,488
Novartis Bioventures Ltd Large shareholder
Transaction date
Sale
Price
23.47
Quantity 14,867 -0.6%
Value US$348,949
Novartis Bioventures Ltd Large shareholder
Transaction date
Sale
Price
23.89
Quantity 10,722 -0.5%
Value US$256,176
Novartis Bioventures Ltd Large shareholder
Transaction date
Sale
Price
23.94
Quantity 35,539 -1.5%
Value US$850,896
Novartis Bioventures Ltd Large shareholder
Transaction date
Sale
Price
25.14
Quantity 5,300 -0.2%
Value US$133,267
Novartis Bioventures Ltd Large shareholder
Transaction date
Sale
Price
25.00
Quantity 53 -0.0%
Value US$1,325
Novartis Bioventures Ltd Large shareholder
Transaction date
Sale
Price
25.01
Quantity 17,451 -0.7%
Value US$436,364
Novartis Bioventures Ltd Large shareholder
Transaction date
Sale
Price
25.50
Quantity 9,019 -0.4%
Value US$229,964
Novartis Bioventures Ltd Large shareholder
Transaction date
Sale
Price
25.51
Quantity 22,534 -0.9%
Value US$574,901
Novartis Bioventures Ltd Large shareholder
Transaction date
Sale
Price
26.33
Quantity 20,081 -0.8%
Value US$528,725
Novartis Bioventures Ltd Large shareholder
Transaction date
Sale
Price
20.91
Quantity 7,778 -0.3%
Value US$162,658
Novartis Bioventures Ltd Large shareholder
Transaction date
Sale
Price
20.86
Quantity 7,847 -0.3%
Value US$163,670
Novartis Bioventures Ltd Large shareholder
Transaction date
Sale
Price
20.96
Quantity 57,844 -2.3%
Value US$1,212,306
Novartis Bioventures Ltd Large shareholder
Transaction date
Sale
Price
20.93
Quantity 5,398 -0.2%
Value US$113,000
Novartis Bioventures Ltd Large shareholder
Transaction date
Sale
Price
21.04
Quantity 4,999 -0.2%
Value US$105,160
Novartis Bioventures Ltd Large shareholder
Transaction date
Sale
Price
21.86
Quantity 749 -0.0%
Value US$16,370
Novo A/S Large shareholder
Transaction date
Purchase
Price
13.00
Quantity 246,154 +13.8%
Value US$3,200,002
SANDELL SCOTT D Large shareholder
Transaction date
Purchase
Price
13.00
Quantity 338,462 +10.7%
Value US$4,400,006
SANDELL SCOTT D Large shareholder
Transaction date
Sale
Price
13.00
Quantity 435 -0.5%
Value US$5,655
KOLLURI KRISHNA KITTU Large shareholder
Transaction date
Purchase
Price
13.00
Quantity 338,462 +10.7%
Value US$4,400,006
KOLLURI KRISHNA KITTU Large shareholder
Transaction date
Sale
Price
13.00
Quantity 435 -0.5%
Value US$5,655
MOTT DAVID M Large shareholder
Transaction date
Purchase
Price
13.00
Quantity 338,462 +10.7%
Value US$4,400,006
MOTT DAVID M Large shareholder
Transaction date
Sale
Price
13.00
Quantity 435 -0.5%
Value US$5,655
MORGENTHALER VENTURE PARTNERS IX LP Large shareholder
Transaction date
Purchase
Price
13.00
Quantity 263,538 +10.6%
Value US$3,425,994
MORGENTHALER VENTURE PARTNERS IX LP Large shareholder
Transaction date
Sale
Price
13.00
Quantity 340 -0.4%
Value US$4,420
Shah Rajeev M. Non-Executive Director
Transaction date
Purchase
Price
13.00
Quantity 161,538 +13.6%
Value US$2,099,994
RA CAPITAL MANAGEMENT, LLC Non-Executive Director
Transaction date
Purchase
Price
13.00
Quantity 161,538 +13.6%
Value US$2,099,994
BARRETT M JAMES Large shareholder
Transaction date
Purchase
Price
13.00
Quantity 338,462 +10.7%
Value US$4,400,006
BARRETT M JAMES Large shareholder
Transaction date
Sale
Price
13.00
Quantity 435 -0.5%
Value US$5,655
Lettmann Jason Non-Executive Director
Transaction date
Purchase
Price
13.00
Quantity 15,633 +0.4%
Value US$203,229
Lettmann Jason Non-Executive Director
Transaction date
Purchase
Price
13.00
Quantity 114,752 +2.9%
Value US$1,491,776
Lettmann Jason Non-Executive Director
Transaction date
Purchase
Price
13.00
Quantity 263,538 +7.2%
Value US$3,425,994
Lettmann Jason Non-Executive Director
Transaction date
Sale
Price
13.00
Quantity 340 -0.4%
Value US$4,420
BARRIS PETER J Large shareholder
Transaction date
Purchase
Price
13.00
Quantity 338,462 +10.7%
Value US$4,400,006
BARRIS PETER J Large shareholder
Transaction date
Sale
Price
13.00
Quantity 435 -0.5%
Value US$5,655
KERINS PATRICK J Large shareholder
Transaction date
Purchase
Price
13.00
Quantity 338,462 +10.7%
Value US$4,400,006
KERINS PATRICK J Large shareholder
Transaction date
Sale
Price
13.00
Quantity 435 -0.5%
Value US$5,655
Weller Harry R Large shareholder
Transaction date
Purchase
Price
13.00
Quantity 338,462 +10.7%
Value US$4,400,006
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-03-18 2020-03-17 PlS Planned sale
Ricardo Alonso

See Remarks

Officer
97,827 +12.6%
383.41
US$1,569,499 		97,827 +12.6% 383.41 US$1,569,499
2020-03-18 2020-03-16 PlS Planned sale
Farzaneh-Far Ramin

Chief Medical Officer

Officer
52,063 -6.7%
25.78
US$3,868,016 		52,063 -6.7% 25.78 US$3,868,016
2020-02-20 2020-02-18 PlS Planned sale
Farzaneh-Far Ramin

Chief Medical Officer

Officer
31,311 -46.3%
44.39
US$1,735,572 		31,311 -46.3% 44.39 US$1,735,572
2020-01-21 2020-01-17 PlS Planned sale
Ricardo Alonso

See Remarks
2,285 -50.0%
47.02
US$107,441 		2,285 -50.0% 47.02 US$107,441
2020-01-16 2020-01-15 PlS Planned sale
Farzaneh-Far Ramin

Chief Medical Officer
10,595 -59.8%
46.95
US$497,441 		10,595 -59.8% 46.95 US$497,441
2019-12-18 2019-12-17 PlS Planned sale Read Simon

Chief Scientific Officer

Officer
10,000 -61.6%
47.08
US$470,821 		10,000 -61.6% 47.08 US$470,821
2019-12-18 2019-12-17 PlS Planned sale Ricardo Alonso

See Remarks

Officer
2,285 -33.3%
47.08
US$107,568 		2,285 -33.3% 47.08 US$107,568
2019-12-18 2019-12-16 PlS Planned sale Farzaneh-Far Ramin

Chief Medical Officer

Officer
10,595 -59.8%
47.23
US$500,351 		10,595 -59.8% 47.23 US$500,351
2019-11-18 2019-11-15 PlS Planned sale Farzaneh-Far Ramin

Chief Medical Officer

Officer
10,595 -59.8%
46.66
US$494,319 		10,595 -59.8% 46.66 US$494,319
2019-11-18 2019-11-14 PlS Planned sale Read Simon

Chief Scientific Officer

Officer
10,000 -61.6%
46.68
US$466,808 		10,000 -61.6% 46.68 US$466,808
2019-10-17 2019-10-17 PlS Planned sale
Ricardo Alonso

See Remarks
2,285 -25.0%
46.70
US$106,710 		2,285 -25.0% 46.70 US$106,710
2019-10-17 2019-10-16 PlS Planned sale
2.8
Read Simon

Chief Scientific Officer
10,000 -61.6%
46.87
US$468,726 		10,000 -61.6% 46.87 US$468,726
2019-10-17 2019-10-15 PlS Planned sale
Farzaneh-Far Ramin

Chief Medical Officer
10,595 -59.8%
46.89
US$496,769 		10,595 -59.8% 46.89 US$496,769
2019-09-16 2019-09-16 PlS Planned sale
Farzaneh-Far Ramin

Chief Medical Officer
10,595 -59.8%
25.26
US$267,675 		10,595 -59.8% 25.26 US$267,675
2019-09-16 2019-09-12 PlS Planned sale
2.8
Read Simon

Chief Scientific Officer
10,000 -61.6%
25.41
US$254,050 		10,000 -61.6% 25.41 US$254,050
2019-08-27 2019-08-23 PlS Planned sale Ricardo Alonso

See Remarks

Officer
2,285 -20.0%
27.89
US$63,740 		2,285 -20.0% 27.89 US$63,740
2019-08-27 2019-08-23 PlS Planned sale Read Simon

Chief Scientific Officer

Officer
10,000 -61.6%
27.77
US$277,703 		10,000 -61.6% 27.77 US$277,703
2019-08-27 2019-08-23 PlS Planned sale Farzaneh-Far Ramin

Chief Medical Officer

Officer
10,595 -59.8%
27.77
US$294,226 		10,595 -59.8% 27.77 US$294,226
2019-07-18 2019-07-17 PlS Planned sale
2.8
Read Simon

Chief Scientific Officer
10,000 -61.6%
32.95
US$329,479 		10,000 -61.6% 32.95 US$329,479
2019-07-16 2019-07-15 PlS Planned sale
Farzaneh-Far Ramin

Chief Medical Officer
4,216 -37.2%
33.29
US$140,338 		4,216 -37.2% 33.29 US$140,338
2019-07-16 2019-07-15 PlS Planned sale
Farzaneh-Far Ramin

Chief Medical Officer
6,379 -36.0%
32.97
US$210,309 		6,379 -36.0% 32.97 US$210,309
2019-06-25 2019-06-21 PlS Planned sale
Ricardo Alonso

See Remarks
2,857 -20.0%
23.72
US$67,782 		2,857 -20.0% 23.72 US$67,782
2019-06-19 2019-06-18 PlS Planned sale
2.8
Read Simon

Chief Scientific Officer
414 -6.2%
23.09
US$9,560 		414 -6.2% 23.09 US$9,560
2019-06-19 2019-06-18 PlS Planned sale
2.8
Read Simon

Chief Scientific Officer
9,586 -59.0%
22.21
US$212,908 		9,586 -59.0% 22.21 US$212,908
2019-06-19 2019-06-17 PlS Planned sale
Farzaneh-Far Ramin

Chief Medical Officer
7,184 -50.2%
22.04
US$158,363 		7,184 -50.2% 22.04 US$158,363
2019-06-19 2019-06-17 PlS Planned sale
Farzaneh-Far Ramin

Chief Medical Officer
3,411 -19.2%
21.41
US$73,021 		3,411 -19.2% 21.41 US$73,021
2018-12-14 2018-12-14 B Purchase Shah Rajeev M. Non-Executive Director Large shareholder
1,006,452 +26.1%
15.50
US$15,600,006 		1,006,452 +26.1% 15.50 US$15,600,006
2018-12-14 2018-12-14 B Purchase NEW ENTERPRISE ASSOCIATES 13 LP Large shareholder
645,161 +11.8%
15.50
US$9,999,996 		645,161 +11.8% 15.50 US$9,999,996
2018-12-14 2018-12-12 B Purchase RA CAPITAL MANAGEMENT, LLC Non-Executive Director Large shareholder
1,006,452 +26.1%
15.50
US$15,600,006 		1,006,452 +26.1% 15.50 US$15,600,006
2018-02-21 2018-02-16 B Purchase NEW ENTERPRISE ASSOCIATES 13 LP Large shareholder
2,000,000 +57.3%
6.00
US$12,000,000 		2,000,000 +57.3% 6.00 US$12,000,000
2018-02-16 2018-02-14 B Purchase RA CAPITAL MANAGEMENT, LLC Non-Executive Director Large shareholder
2,500,000 +184.9%
6.00
US$15,000,000 		2,500,000 +184.9% 6.00 US$15,000,000
2018-02-16 2018-02-14 B Purchase Shah Rajeev M. Non-Executive Director Large shareholder
2,500,000 +184.9%
6.00
US$15,000,000 		2,500,000 +184.9% 6.00 US$15,000,000
2017-06-20 2017-06-19 S Sale Novartis Bioventures Ltd Large shareholder
3,220 -0.1%
22.02
US$70,899 		3,220 -0.1% 22.02 US$70,899
2017-06-20 2017-06-16 S Sale Novartis Bioventures Ltd Large shareholder
53,200 -2.3%
21.24
US$1,130,207 		53,200 -2.3% 21.24 US$1,130,207
2017-06-12 2017-06-08 S Sale Novartis Bioventures Ltd Large shareholder
700 -0.0%
22.00
US$15,400 		700 -0.0% 22.00 US$15,400
2017-06-08 2017-06-07 S Sale Novartis Bioventures Ltd Large shareholder
4,840 -0.2%
22.11
US$106,999 		4,840 -0.2% 22.11 US$106,999
2017-06-08 2017-06-06 S Sale Novartis Bioventures Ltd Large shareholder
7,274 -0.3%
22.98
US$167,161 		7,274 -0.3% 22.98 US$167,161
2017-06-06 2017-06-05 S Sale Novartis Bioventures Ltd Large shareholder
4,780 -0.2%
23.11
US$110,488 		4,780 -0.2% 23.11 US$110,488
2017-06-06 2017-06-02 S Sale Novartis Bioventures Ltd Large shareholder
14,867 -0.6%
23.47
US$348,949 		14,867 -0.6% 23.47 US$348,949
2017-06-02 2017-06-01 S Sale Novartis Bioventures Ltd Large shareholder
10,722 -0.5%
23.89
US$256,176 		10,722 -0.5% 23.89 US$256,176
2017-06-02 2017-05-31 S Sale Novartis Bioventures Ltd Large shareholder
35,539 -1.5%
23.94
US$850,896 		35,539 -1.5% 23.94 US$850,896
2017-05-30 2017-05-26 S Sale Novartis Bioventures Ltd Large shareholder
5,300 -0.2%
25.14
US$133,267 		5,300 -0.2% 25.14 US$133,267
2017-05-30 2017-05-25 S Sale Novartis Bioventures Ltd Large shareholder
53 -0.0%
25.00
US$1,325 		53 -0.0% 25.00 US$1,325
2017-05-25 2017-05-24 S Sale Novartis Bioventures Ltd Large shareholder
17,451 -0.7%
25.01
US$436,364 		17,451 -0.7% 25.01 US$436,364
2017-05-22 2017-05-18 S Sale Novartis Bioventures Ltd Large shareholder
9,019 -0.4%
25.50
US$229,964 		9,019 -0.4% 25.50 US$229,964
2017-05-18 2017-05-17 S Sale Novartis Bioventures Ltd Large shareholder
22,534 -0.9%
25.51
US$574,901 		22,534 -0.9% 25.51 US$574,901
2017-05-18 2017-05-16 S Sale Novartis Bioventures Ltd Large shareholder
20,081 -0.8%
26.33
US$528,725 		20,081 -0.8% 26.33 US$528,725
2017-05-02 2017-03-01 S Sale Novartis Bioventures Ltd Large shareholder
7,778 -0.3%
20.91
US$162,658 		7,778 -0.3% 20.91 US$162,658
2017-05-02 2017-02-28 S Sale Novartis Bioventures Ltd Large shareholder
7,847 -0.3%
20.86
US$163,670 		7,847 -0.3% 20.86 US$163,670
2017-05-02 2017-02-27 S Sale Novartis Bioventures Ltd Large shareholder
57,844 -2.3%
20.96
US$1,212,306 		57,844 -2.3% 20.96 US$1,212,306
2017-05-02 2017-02-24 S Sale Novartis Bioventures Ltd Large shareholder
5,398 -0.2%
20.93
US$113,000 		5,398 -0.2% 20.93 US$113,000
2017-05-02 2017-02-23 S Sale Novartis Bioventures Ltd Large shareholder
4,999 -0.2%
21.04
US$105,160 		4,999 -0.2% 21.04 US$105,160
2017-05-02 2017-02-22 S Sale Novartis Bioventures Ltd Large shareholder
749 -0.0%
21.86
US$16,370 		749 -0.0% 21.86 US$16,370
2016-11-02 2016-10-31 B Purchase Novo A/S Large shareholder
246,154 +13.8%
13.00
US$3,200,002 		246,154 +13.8% 13.00 US$3,200,002
2016-10-31 2016-10-31 B Purchase SANDELL SCOTT D Large shareholder
338,462 +10.7%
13.00
US$4,400,006 		338,462 +10.7% 13.00 US$4,400,006
2016-10-31 2016-10-31 S Sale SANDELL SCOTT D Large shareholder
435 -0.5%
13.00
US$5,655 		435 -0.5% 13.00 US$5,655
2016-10-31 2016-10-31 B Purchase KOLLURI KRISHNA KITTU Large shareholder
338,462 +10.7%
13.00
US$4,400,006 		338,462 +10.7% 13.00 US$4,400,006
2016-10-31 2016-10-31 S Sale KOLLURI KRISHNA KITTU Large shareholder
435 -0.5%
13.00
US$5,655 		435 -0.5% 13.00 US$5,655
2016-10-31 2016-10-31 B Purchase MOTT DAVID M Large shareholder
338,462 +10.7%
13.00
US$4,400,006 		338,462 +10.7% 13.00 US$4,400,006
2016-10-31 2016-10-31 S Sale MOTT DAVID M Large shareholder
435 -0.5%
13.00
US$5,655 		435 -0.5% 13.00 US$5,655
2016-10-31 2016-10-31 B Purchase MORGENTHALER VENTURE PARTNERS IX LP Large shareholder
263,538 +10.6%
13.00
US$3,425,994 		263,538 +10.6% 13.00 US$3,425,994
2016-10-31 2016-10-31 S Sale MORGENTHALER VENTURE PARTNERS IX LP Large shareholder
340 -0.4%
13.00
US$4,420 		340 -0.4% 13.00 US$4,420
2016-10-31 2016-10-31 B Purchase Shah Rajeev M. Non-Executive Director
161,538 +13.6%
13.00
US$2,099,994 		161,538 +13.6% 13.00 US$2,099,994
2016-10-31 2016-10-31 B Purchase RA CAPITAL MANAGEMENT, LLC Non-Executive Director
161,538 +13.6%
13.00
US$2,099,994 		161,538 +13.6% 13.00 US$2,099,994
2016-10-31 2016-10-31 B Purchase BARRETT M JAMES Large shareholder
338,462 +10.7%
13.00
US$4,400,006 		338,462 +10.7% 13.00 US$4,400,006
2016-10-31 2016-10-31 S Sale BARRETT M JAMES Large shareholder
435 -0.5%
13.00
US$5,655 		435 -0.5% 13.00 US$5,655
2016-10-31 2016-10-31 B Purchase Lettmann Jason Non-Executive Director
15,633 +0.4%
13.00
US$203,229 		15,633 +0.4% 13.00 US$203,229
2016-10-31 2016-10-31 B Purchase Lettmann Jason Non-Executive Director
114,752 +2.9%
13.00
US$1,491,776 		114,752 +2.9% 13.00 US$1,491,776
2016-10-31 2016-10-31 B Purchase Lettmann Jason Non-Executive Director
263,538 +7.2%
13.00
US$3,425,994 		263,538 +7.2% 13.00 US$3,425,994
2016-10-31 2016-10-31 S Sale Lettmann Jason Non-Executive Director
340 -0.4%
13.00
US$4,420 		340 -0.4% 13.00 US$4,420
2016-10-31 2016-10-31 B Purchase BARRIS PETER J Large shareholder
338,462 +10.7%
13.00
US$4,400,006 		338,462 +10.7% 13.00 US$4,400,006
2016-10-31 2016-10-31 S Sale BARRIS PETER J Large shareholder
435 -0.5%
13.00
US$5,655 		435 -0.5% 13.00 US$5,655
2016-10-31 2016-10-31 B Purchase KERINS PATRICK J Large shareholder
338,462 +10.7%
13.00
US$4,400,006 		338,462 +10.7% 13.00 US$4,400,006
2016-10-31 2016-10-31 S Sale KERINS PATRICK J Large shareholder
435 -0.5%
13.00
US$5,655 		435 -0.5% 13.00 US$5,655
2016-10-31 2016-10-31 B Purchase Weller Harry R Large shareholder
338,462 +10.7%
13.00
US$4,400,006 		338,462 +10.7% 13.00 US$4,400,006
Explore more

More insider trading research around Ra Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America